Mkts

Core Laboratories Inc.

NYSE: CLB
$8.84-0.09 (-1.01%)
As of Nov 6, 9:30 AM ET

Key statistics

Day range
8.759.00
52-week range
8.7520.36
Today
Open8.94
Previous close8.84
Volume706.0K
Valuation
Market cap454.72M
P/E ratio18.67×
EPS (TTM)0.52
Income & risk
Dividend / yield0.04 / 0.16%
Beta1.20
Avg volume755.3K
Discussion

CLB News

Stories mentioning CLB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue121,797138,255134,521130,159123,585129,237134,397130,577
Cost of Goods Sold102,073109,516104,901103,70199,469106,199106,805102,930
Gross Profit19,72428,73929,62026,45824,11623,03827,59227,647
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)1,88715,83220,92815,2914,41714,17419,80316,008
Interest Income
Interest Expense2,8912,6092,6502,7112,6022,6293,1083,209
Other Expense645.001,3925,5902,967(2,335)3,8804,5292,390
Pretax Income(1,004)13,22318,27812,5801,81511,54516,69512,799
Tax Provision(251.00)8,0943,7541,9111,7464,0764,6913,609
Net Income (Loss)(789.00)4,94814,23910,636(154.00)7,40311,7459,032
Earnings Per Share (Basic)(0.02)0.110.310.230.000.160.250.19
Earnings Per Share (Diluted)(0.02)0.110.300.220.000.160.250.19
Weighted Average Shares Outstanding (Basic)46,07346,42746,26346,63246,77346,89746,92246,908
Weighted Average Shares Outstanding (Diluted)46,07347,02847,07847,36446,77347,68547,82047,743

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CLB

Core Laboratories Inc. (NYSE: CLB) is a stock listed on the New York Stock Exchange under the ticker symbol CLB. It last traded at $8.84 (Nov 6, 2026, 9:30 AM ET), down 1.0% on the day. That gives Core Laboratories a market capitalisation of $454.7M and a price-to-earnings ratio of 18.7.

Over the past 52 weeks CLB has traded between $8.75 and $20.36.

Revenue for the quarter ended Mar 31, 2026 was $121.8M; a net loss of $789.0K. Revenue was down 1.4% from $123.6M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$121.8M-$789.0K-0.6%
Dec 31, 2025$138.3M$4.9M3.6%
Sep 30, 2025$134.5M$14.2M10.6%
Jun 30, 2025$130.2M$10.6M8.2%

From Core Laboratories’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…